Ministry of Food and Drug Safety Enhances Regulatory Reliance in Thailand Pharmaceutical Market
Ministry Addresses Drug Approval Hurdles
South Korea's Ministry of Food and Drug Safety engaged Thai regulators in a forum aimed at addressing challenges in securing drug approvals within Thailand's pharmaceutical market. This initiative included 10 domestic pharmaceutical companies that conveyed the obstacles faced during the registration process.
Regulatory Reliance Discussion
During the discussion, the ministry explored reliance-based regulatory frameworks with the Thai Food and Drug Administration. This framework enables the recognition of foreign regulatory agencies as reference bodies, potentially easing the approval pathway for Korean medicines.
- Korea-Thailand Pharmaceutical Forum facilitated crucial dialogues on compliance and collaboration.
- Participants included officials from both nations' regulatory bodies and industry.
- Key focus on sharing insights into the drug approval systems and improving investment landscapes.
Korean Companies' Market Engagement
Both sides examined opportunities for technological cooperation and distribution partnerships. Senior officials shared best practices from the Korean experiences in navigating the Thai pharmaceutical market.
- Effective communication between regulatory bodies is essential for reducing burdens on approvals.
- The ministry highlighted the importance of a streamlined process to support the entry of Korean drugs.
As Thailand emerges as the third-largest pharmaceutical market in Southeast Asia, this collaboration is anticipated to enhance bilateral cooperation and market entry for Korean drug manufacturers. The forum marked a significant step in fostering long-term partnerships in the bio-health sector.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.